EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A real-world clustering analysis reveals heterogeneous response patterns to biologic therapy in severe asthma

Shuichiro Matsumoto, Yosuke Kamide, Naoya Fujino, Mitsuhiro Yamada, Yoshinao Ono, Seiichi Kobayashi, Teruyuki Sato, Kiyoshi Sekiya, Takuto Endo, Tsutomu Tamada, Tomohiro Ichikawa, Hiroyuki Aizawa und 8 weitere

Exploration of Asthma & Allergy · 2025

DOI: 10.37349/eaa.2025.100990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Asthma & Allergy, 2025. Verfasst von Shuichiro Matsumoto und 19 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Despite the revolutionary impact of biologics (Bx) on severe asthma management, predicting individual treatment responses remains challenging. We aimed to characterize the heterogeneous nature of clinical status and disease activity in patients with severe asthma after biologic therapies through a comprehensive evaluation of real-world clinical outcomes.

Methods

In this retrospective, multicenter study of 53 patients with severe asthma who received biologic therapies, hierarchical clustering analysis was performed based on three key parameters during treatment: exacerbation, maintenance oral corticosteroid (mOCS) dose, and lung function. Canonical correlation analysis and multinomial logistic regression were used to identify predictors of response patterns.

Results

Clustering analysis revealed three distinct control groups: well-controlled (n = 23), moderately controlled (n = 22), and poorly controlled (n = 8). Well-controlled patients exhibited minimal exacerbations, no oral corticosteroid (OCS) use, and optimal or stabilized lung function. Moderately controlled patients showed minimal exacerbations and no mOCS use but variable lung function improvements. Poorly controlled patients exhibited persistent exacerbations, mOCS dependence, or both with limited lung function improvement. Baseline forced expiratory volume in 1 second (FEV1) %predicted (percent predicted FEV1) values and blood eosinophil counts independently differentiated well-controlled from moderately controlled patients, whereas baseline mOCS use distinguished moderately controlled from poorly controlled patients.

Conclusions

Our findings reveal distinct patterns of disease control following biologic therapy in severe asthma, with baseline lung function, eosinophilic inflammation, and OCS use as key predictive factors. These results support the need for personalized treatment approaches in severe asthma management.

Zitieren

APA

Matsumoto, S., Kamide, Y., Fujino, N., Yamada, M., Ono, Y., Kobayashi, S., Sato, T., Sekiya, K., Endo, T., Tamada, T., Ichikawa, T., Aizawa, H., Sano, H., Kyogoku, Y., Saito, T., Konno, S., Suzuki, M., Okutomo, K., Taniguchi, M., & Sugiura, H. (2025). A real-world clustering analysis reveals heterogeneous response patterns to biologic therapy in severe asthma. Exploration of Asthma & Allergy. https://doi.org/10.37349/eaa.2025.100990

Vancouver

Matsumoto S, Kamide Y, Fujino N, Yamada M, Ono Y, Kobayashi S, et al. A real-world clustering analysis reveals heterogeneous response patterns to biologic therapy in severe asthma. Exploration of Asthma & Allergy. 2025. doi:10.37349/eaa.2025.100990

BibTeX
@article{Matsumoto2025,
  author = {Matsumoto, Shuichiro and Kamide, Yosuke and Fujino, Naoya and Yamada, Mitsuhiro and Ono, Yoshinao and Kobayashi, Seiichi and Sato, Teruyuki and Sekiya, Kiyoshi and Endo, Takuto and Tamada, Tsutomu and Ichikawa, Tomohiro and Aizawa, Hiroyuki and Sano, Hirohito and Kyogoku, Yorihiko and Saito, Takuya and Konno, Shuichi and Suzuki, Manami and Okutomo, Koji and Taniguchi, Masami and Sugiura, Hisatoshi},
  title = {A real-world clustering analysis reveals heterogeneous response patterns to biologic therapy in severe asthma},
  journal = {Exploration of Asthma & Allergy},
  year = {2025},
  doi = {10.37349/eaa.2025.100990}
}
Kostenlos starten →